TrialPloS one2026

Health-related quality of life with adjuvant immune checkpoint inhibition in renal cell carcinoma: A qualitative study of UK participants in the phase III RAMPART trial.

Sophie Merrick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.